InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,099.96
(
1.02%
)
US TECH 100
17,238.00
(
1.53%
)
Dow Jones
38,239.66
(
0.40%
)
Brent Oil
88.17
(
0.02%
)
Bitcoin
63,804.06
(
-1.07%
)
Post# of 648882
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Tuff-Stuff

Send PM Follow Ignore
Followers 219
Posts 247348
Boards Moderated 2
Alias Born 04/06/2006

Tuff-Stuff

Re: None

Monday, 01/23/2017 7:09:44 AM

Monday, January 23, 2017 7:09:44 AM

Post# of 648882
The FDA grants 510(k) clearance for Becton, Dickinson's (NYSE:BDX) PleurX catheter system for use in specific non-malignant recurrent pleural effusions etiologies, including congestive heart failure. A pleural effusion is a collection of fluid that accumulates in the pleural cavity that surrounds the lungs that causes the person to be short of breath.

The PleurX system allows the patient to drain pleural fluid in a home setting. It was initially approved in 1997 for managing malignant and recurrent pleural effusions.

Pray for A Pain Free Day!

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up